Vascular pathology is frequently found in the brains of patients with Alzheimer's disease (AD). The aim of this study is to assess the frequency of vascular pathology in the brain in AD patients in a systematic manner and its clinical significance at presentation. A series of 51 patients with mild to moderate AD were consecutively enrolled. At baseline, every patient underwent the following clinical scales: Mini-Mental, Clinical Dementia Rating Scale, Ischemic Scale, Blessed Dementia Rating Scale, Alzheimer's Disease Assessment Scale Cognitive Subscale, Neuropsychiatric Inventory, and an Activities of Daily Living Scale (Disability Assessment for Dementia). We also carried out magnetic resonance imaging of the brain and color echo Doppler of carotids to measure the intima-media thickness. White matter hyperintensities were quantitatively evaluated with the Wahlund scale. We did not find correlation between intima-media thicknesses of carotids and clinical scales and between the Wahlund scale and clinical scales. The presence or absence of both microinfarctions and hypertension had no influence in the scores of the clinical scales. We conclude that the vascular component is common in AD but only as coincident pathology.
Erkinjuntti T.Cerebrovascular dementia. Pathophysiology, diagnosis and treatment. CNSDrugs. 1999;12:35-48.
2.
Rockwood K., Wentzel T., Hachinski V., Hogan DB, MacKnight C., McDowell I.Prevalence and outcomes of vascular cognitive impairment. Neurology. 2000;54: 447-451.
3.
Rockwood K., Bowler J., Erkinjuntti T., Hachinski V., Wallin A.Subtypes of vascular dementia. Alzheimer Dis Assoc Disord . 1999;13:59-63.
4.
Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesberry WRBrain infarction and the clinical expression of Alzheimer disease. JAMA. 1997;277: 813-817.
5.
Skoog I., Kalaria RN, Breteler MMVascular factors and Alzheimer disease. Alzheimer Dis Assoc Disord. 1999; 13(suppl 3):106-114.
6.
Kalaria RN, Ballard C.Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord. 1999;13(suppl 3):115-123.
7.
Jellinger KA , Attems J.Prevalence and impact of cerebrovascular pathology in Alzheimer's disease and parkinsonism. Acta Neurol Scand . 2006;114:38-46.
8.
Wilkinson D. , Doody R., Helme R., et al. Donepezil in vascular dementia: a randomized placebo controlled study. Neurology. 2003;61:479-486.
9.
Black S., Roman GC, Geldmacher DS, et al. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial. Stroke. 2003;34: 2323-2330.
10.
Erkinjuntti T., Kurz A., Gauthier S., Bullock R., Lilienfeld S., Damaraju CVEfficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet. 2002; 359:1283-1290.
11.
McKhan G., Drachman D., Folstein M., Katzman R., Price D., Stadlan EMClinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group. Neurology. 1984;34:939-944.
12.
Perry E., Ziabreva I., Perry R., Aarsland D., Ballard C.Absence of cholinergic deficits in pure vascular dementia. Neurology. 2005;64:132-133.
13.
Gold G., Giannakopoulos P., Montes-Paixao Júnior C., et al. Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia. Neurology. 1997; 49:690-694.
14.
Rosen WG, Mohs RC, Davis KLA new rating scale for Alzheimer's disease. Am J Psychiatry . 1984;141: 1356-1364.
15.
Cummings JL , Mega M., Gray K., Rosenberg-Thompson S., Carusi DA, Gornbein J.The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308-2314.
16.
Gelinas I., Gauthier L., McIntire M., Gauthier S.Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia. Am J Occup Ther. 1999;53:471-481.
17.
Wahlund LO, Barkhof F., Fazekas F., et al. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke. 2001;32:1318-1322.
18.
Zekry D., Duyckaerts C., Belmin J., Geoffre C., Moulias R., Hauw JJAlzheimer's disease and brain infarcts in the elderly. Agreement with neuropathology. J Neurol. 2002; 249:1529-1534.
19.
Fernando MS , Ince PG;MRC Cognitive. Function and Ageing Neuropathology Study Group. Vascular pathologies and cognition in a population-based cohort of elderly people. J Neurol Sci.2004;226:13-17.
20.
Nagga K., Radberg C., Marcusson J.CT brain findings in clinical dementia investigation. Underestimation of mixed dementia. Dement Geriatr Cogn Disord. 2004; 18:59-66.
21.
Hofman A., Ott A., Breteler MM, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 1997; 349:151-154.
22.
van Oijen M. , de Jong FJ, Witteman JC, Hofman A., Koudstaal PJ, Breteler MMAtherosclerosis and risk for dementia. Ann Neurol. 2007;61:403-410.
23.
Del Ser T., Hachinski V., Merskey H., Munoz DGAlzheimer's disease with and without cerebral infarcts. J Neurol Sci. 2005;231:3-11.
24.
Regan C., Katona C., Walker Z., Hooper J., Donovan J., Livingston G.Relationship of vascular risk to the progression of Alzheimer disease. Neurology. 2006;67: 1357-1362.
25.
Mungas D., Reed BR, Jagust WJ, et al. Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease. Neurology. 2002;59:867-873.
26.
Doddy RS, Massman PJ, Mawad M., Nance M.Cognitive consequences of subcortical magnetic resonance imaging changes in Alzheimer's disease: comparison to small vessel ischemic vascular dementia . Neuropsychiatry Neuropsychol Behav Neurol. 1998;11:191-199.
27.
Bronge L., Wahlund LOPrognostic significance of white matter changes in a memory clinic population . Psychiatry Res. 2003;122:199-206.
28.
Diaz JF, Merskey H., Hachinski VC, et al. Improved recognition of leukoaraiosis and cognitive impairment in Alzheimer's disease. Arch Neurol.1991;48:1022-1025.
29.
Wolf H., Ecke GM, Bettin S., Dietrich J., Gertz HJDo white matter changes contribute to the subsequent development of dementia in patients with mild cognitive impairment? A longitudinal study. Int J Geriatr Psychiatry. 2000;15:803-812.
30.
Reed BR, Eberling JL, Mungas D., Weiner M., Kramer JH, Jagust WJEffects of white matter lesions and lacunes on cortical function. Arch Neurol. 2004;61:1545-1550.
31.
Tullberg M. , Fletcher E., DeCarli C., et al. White matter lesions impair frontal lobe functions regardless of their location. Neurology. 2004;63:246-253.
32.
Jellinger KA , Attems J.Neuropathological evaluation of mixed dementia . J Neurol Sci. 2007;257:80-87.
33.
Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001; 56:1143-1153.
